Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | VP, Controller and Treasurer | February 15, 2024 | February 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date February 15, 2024 · Filed February 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,213 |
Ending reported balance
After 2024-02-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-02-15 · Exercise / conversion · Acquired 6,668 · Balance 8,591 F1: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Row 2 · 2024-02-15 · Tax withholding · Disposed 2,378 · Balance 6,213 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 13,332 |
Reported balance
After 2024-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-02-15 · Exercise / conversion · Disposed 6,668 · Balance 13,332 F1: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2024 Filed Feb 20, 2024 23:04 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 6,668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000039 · wk-form4_1708470273.xml · derivative · entry 3 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,332 Underlying: Common Stock · 6,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 23:04 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 2,378 | $17.40 | $41,377.20 |
DisclosureSEC source: 0001125345-24-000039 · wk-form4_1708470273.xml · nonDerivative · entry 2 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,213 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 23:04 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 6,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000039 · wk-form4_1708470273.xml · nonDerivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:32 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 17,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000024 · wk-form4_1707777166.xml · derivative · entry 2 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:32 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 45,000 | $18.30 Strike: $18.30 | $823,500.00 |
DisclosureSEC source: 0001125345-24-000024 · wk-form4_1707777166.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-02-08 F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:28 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-23-000032 · wf-form4_167666929868389.xml · derivative · entry 2 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:28 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001125345-23-000032 · wf-form4_167666929868389.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:46 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 63,400 | $0.00 Strike: $10.15 | $0.00 |
DisclosureSEC source: 0001125345-22-000026 · wf-form4_164574998533509.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,400 Underlying: Common Stock · 63,400 shares Expires 2032-02-22 F1 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 23:01 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 40,000 | $0.00 Strike: $19.18 | $0.00 |
DisclosureSEC source: 0001125345-21-000023 · wf-form4_161420765311881.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:47 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 35,000 | $11.50 Strike: $11.50 | $402,500.00 |
DisclosureSEC source: 0001125345-20-000026 · wf-form4_158258081922732.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:01 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 35,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000030 · wf-form4_155112849544101.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:22 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 28,000 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000040 · wf-form4_152037494752620.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2028-03-02 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,989 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · derivative · entry 7 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,989 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,989 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · derivative · entry 6 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,989 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,989 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · derivative · entry 5 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,989 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 23,967 | $25.01 | $599,436.24 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 4 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.14. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 7,989 | $1.51 | $12,063.39 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 3 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 7,989 | $0.94 | $7,509.66 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 2 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 7,989 | $0.94 | $7,509.66 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 22:46 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantCommon Stock · Derivative | 28,000 | $20.53 Strike: $20.53 | $574,840.00 |
DisclosureSEC source: 0001125345-17-000036 · wf-form4_148728517655735.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2027-02-15 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:49 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,994 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001552781-16-001976 · e00528_cilinski-form4.xml · derivative · entry 4 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,994 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:49 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,237 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001552781-16-001976 · e00528_cilinski-form4.xml · derivative · entry 3 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,237 shares Expires 2019-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:49 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 6,231 | $29.28 | $182,443.68 |
DisclosureSEC source: 0001552781-16-001976 · e00528_cilinski-form4.xml · nonDerivative · entry 2 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 F1 · security: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $28.755 to $29.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:49 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 6,231 | $0.94 | $5,857.14 |
DisclosureSEC source: 0001552781-16-001976 · e00528_cilinski-form4.xml · nonDerivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.